Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
-51.87x90.58x0.89x17.46x-57.69x-56.89x-.--% 3.01TCr
41.47x6.5x2.02x9.67x34.91x35.61x0.03% 4.3TCr
15.59x3.77x0.2x5.54x12.2x13.33x1.92% 3.92TCr
-17.46x1.05x6.12x4.3x-8.04x-6.31x-.--% 2.19TCr
27.73x2.6x0.68x5.41x15.05x18.82x-.--% 1.82TCr
21.68x2.5x-1.13x4.07x13.29x15.17x-.--% 1.6TCr
-316.87x11.38x6.48x26.28x1446.95x-317.41x-.--% 1.3TCr
-14.42x63.1x0.69x6446.99x-18.43x-13.91x-.--% 1.25TCr
-164.89x18.21x-1.91x40.26x-159.9x-145.87x-.--% 1.18TCr
13.48x3.47x1.34x3.75x8.89x10x-.--% 1.07TCr
-88.15x16.88x1.45x6.51x-97.25x-67.12x-.--% 1.02TCr
-7.39x - -0.24x - -6.52x-6.33x-.--% 785.52Cr
-215.25x16.96x2.48x19.27x343.19x-437.09x-.--% 805.5Cr
-32.77x - 1x - - - - 862.59Cr
32.82x6.24x0.69x9.48x23.88x24.58x0.26% 758.6Cr
-17.2x7.62x6.49x484.94x-14.6x-14.99x-.--% 769.9Cr
-15.93x14.34x-0x15.21x-21.63x-15.24x-.--% 770.88Cr
-9.31x-29.81x6.9x74.85x-10.07x-9.68x-.--% 739.72Cr
97.21x2.14x-1.82x4.26x20.97x45.04x0.15% 671.11Cr
Average -36.92x 13.97x 1.70x 422.25x 84.73x -51.57x 0.13% 1.52TCr
Weighted average by Cap. -24.90x 17.55x 1.63x 322.29x 67.93x -32.83x 0.28%
Bio Therapeutic Drugs
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW